The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D

被引:13
|
作者
Hawton, A. [1 ]
Green, C. [1 ]
Telford, C. J. [1 ]
Wright, D. E. [2 ]
Zajicek, J. P. [3 ]
机构
[1] Univ Exeter, Hlth Econ Grp, PenCLAHRC, Peninsula Coll Med & Dent, Exeter EX2 4SG, Devon, England
[2] Univ Plymouth, Ctr Hlth & Environm Stat, Plymouth PL4 8AA, Devon, England
[3] Univ Plymouth, Clin Neurol Res Grp, Peninsula Coll Med & Dent, Plymouth PL4 8AA, Devon, England
关键词
cost effectiveness; decision making; multiple sclerosis; outcomes research; quality of life; walking; DISEASE QUESTIONNAIRE; PATIENT; IMPACT; QUALITY; INDEX; LIFE; IMPAIRMENT; DISABILITY; MOBILITY; UTILITY;
D O I
10.1177/1352458511429319
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Walking impairment has a major influence on the quality of life of people with multiple sclerosis (MS). The Multiple Sclerosis Walking Scale (MSWS-12) assesses the impact of MS on walking ability from the patient's perspective, but in its current form, is not amenable for use in many policy decision-making settings. Objectives: Statistical 'mapping' methods were used to convert MSWS-12 scores to EQ-5D health state values. Methods: The relationship between the measures was estimated using cohort data from people with MS in South West England. Regression analyses were conducted, estimation errors assessed, and predictive performance of the best models tested using longitudinal data. Results: Model performance was in line with that of other mapping studies, with the best-performing models being an ordinary least squares (OLS) model using MSWS-12 item scores, and an OLS model using the total MSWS-12 score and its squared term. Conclusions: A process has been described whereby data from a patient-reported outcome measure (MSWS-12) can be converted to (EQ-5D) health state values. These values may be used to consider the health-related quality of life of people with MS, to estimate quality adjusted life-years for use in effectiveness and cost-effectiveness analyses, and to inform health policy decisions.
引用
收藏
页码:853 / 861
页数:9
相关论文
共 28 条
  • [21] A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions
    Shaw, James W.
    Bennett, Bryan
    Trigg, Andrew
    DeRosa, Michael
    Taylor, Fiona
    Kiff, Christopher
    Ntais, Dionysios
    Noon, Katie
    King, Madeleine T.
    Cocks, Kim
    VALUE IN HEALTH, 2021, 24 (11) : 1651 - 1659
  • [22] The Use of Generic Patient-Reported Outcome Measures in Emergency Department Surveys: Discriminant Validity Evidence for the Veterans RAND 12-Item Health Survey and the EQ-5D
    Kwon, Jae-Yung
    Cuthbertson, Lena
    Sawatzky, Richard
    VALUE IN HEALTH, 2022, 25 (12) : 1939 - 1946
  • [23] SENSITIVITY OF EQ-5D TO ASSESS HEALTH-RELATED QUALITY OF LIFE (HRQOL) FOR TRIPLE-CLASS EXPOSED (TCE) RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): KARMMA-3 CASE STUDY EXPLORING EQ-5D MAPPED FROM DISEASE-SPECIFIC INSTRUMENTS
    Paul, E.
    McLoone, D.
    Eliason, L.
    Karampampa, K.
    Pepper, A. N.
    Cope, S.
    Dhanda, D.
    VALUE IN HEALTH, 2023, 26 (12) : S463 - S463
  • [24] Health State Values Derived from People with Multiple Sclerosis for a Condition-Specific Preference-Based Measure: Multiple Sclerosis Impact Scale-Eight Dimensions-Patient Version (MSIS-8D-P)
    Goodwin, Elizabeth
    Green, Colin
    Hawton, Annie
    VALUE IN HEALTH, 2018, 21 (11) : 1338 - 1345
  • [25] ESTIMATING HEALTH RELATED QUALITY OF LIFE EFFECTS IN VITILIGO: MAPPING EQ-5D-5L UTILITIES FROM VITILIGO SPECIFIC SCALES, RE-PIGMENTATION MEASURES USING DATA FROM THE HI-LIGHT TRIAL
    Begum, R.
    Crott, R.
    Martina, R.
    Loizidou, E.
    Khan, I
    VALUE IN HEALTH, 2023, 26 (12) : S109 - S109
  • [26] Estimating health related quality of life effects in vitiligo. Mapping EQ-5D-5 L utilities from vitiligo specific scales: VNS, VitiQoL and re-pigmentation measures using data from the HI-Light trial
    Rabiah Begum
    Ralph Crott
    Reynaldo Martina
    Eleni M. Loizidou
    Iftekhar Khan
    Health and Quality of Life Outcomes, 21
  • [27] Estimating health related quality of life effects in vitiligo. Mapping EQ-5D-5 L utilities from vitiligo specific scales: VNS, VitiQoL and re-pigmentation measures using data from the HI-Light trial
    Begum, Rabiah
    Crott, Ralph
    Martina, Reynaldo
    Loizidou, Eleni M.
    Khan, Iftekhar
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2023, 21 (01)
  • [28] COMPARISON OF THE PSYCHOMETRIC PERFORMANCE OF A NEW CONDITION-SPECIFIC PREFERENCE-BASED MEASURE DERIVED FROM THE CFQ-R (CFQ-R-8D) TO EQ-5D-3L AND SF-6D TO EVALUATE HEALTH-RELATED QUALITY-OF LIFE (HRQOL) IN PEOPLE WITH CYSTIC FIBROSIS (CF)
    Mukuria, C.
    Rowen, D.
    Brazier, J. E.
    McGarry, L.
    Quittner, A.
    Lou, Y.
    Sosnay, P.
    Acaster, S.
    VALUE IN HEALTH, 2020, 23 : S689 - S689